Skip to main content
SpringerLink
Log in

Elevated lymphatic vessel density measured by Lyve-1 expression in areas of replacement fibrosis in the ventricular septum of patients with hypertrophic obstructive cardiomyopathy (HOCM)

  • Original Article
  • Published:
Heart and Vessels Aims and scope Submit manuscript

Abstract

Lymphatic microvessel density (LMVD) contributes to fibrosis in patients with myocardial infarction. However, the role of LMVD in the process of myocardial fibrosis in hypertrophic obstructive cardiomyopathy (HOCM) patients is unclear. We studied LMVD in ventricular septal (VS) samples from 52 individuals (42 was HOCM patients who underwent a transaortic extended septal myectomy, and 10 traffic accident victims), and examined the relationships between the LMVD stained immunohistochemically with lymphatic vessel endothelial hyaluronan receptor (LYVE-1) antibodies, collagen volume fraction (CVF), and clinical characteristics. Compared with traffic accident victims, LMVD was significantly increased in VS of HOCM patients (132.0 ± 49.0 VS 57.8 ± 48.8/mm2, p = 0.000). HOCM patients with syncope had higher level of LMVD than without syncope [166.7 (131.0–201.1) VS 116.4 (80.7–152.1)/mm2, p = 0.017], and LMVD were positively correlated with Log (CVF) (r = 0.431, p = 0.004). On multiple variables regression analysis, LMVD was independently associated with Log (CVF) (r = 0.379, p = 0.009) and syncope (r = 0.335, p = 0.020). In conclusions, the LYVE-1-positive lymphatics have close associations with VS fibrosis in HOCM patients.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4

Similar content being viewed by others

References

  1. Ho CY, Lopez B, Coelho-Filho OR, Lakdawala NK, Cirino AL, Jarolim P, Kwong R, Gonzalez A, Colan SD, Seidman JG, Diez J, Seidman CE (2010) Myocardial fibrosis as an early manifestation of hypertrophic cardiomyopathy. N Engl J Med 363:552–563

    Article  CAS  Google Scholar 

  2. Steggerda RC, Damman K, Balt JC, Liebregts M, Ten BJ, van den Berg MP (2014) Periprocedural complications and long-term outcome after alcohol septal ablation versus surgical myectomy in hypertrophic obstructive cardiomyopathy: a single-center experience. JACC Cardiovasc Interv 7:1227–1234

    Article  Google Scholar 

  3. Maron BJ, Maron MS (2013) Hypertrophic cardiomyopathy. Lancet 381:242–255

    Article  Google Scholar 

  4. Maron BJ, Ommen SR, Semsarian C, Spirito P, Olivotto I, Maron MS (2014) Hypertrophic cardiomyopathy: present and future, with translation into contemporary cardiovascular medicine. J Am Coll Cardiol 64:83–99

    Article  Google Scholar 

  5. O'Hanlon R, Grasso A, Roughton M, Moon JC, Clark S, Wage R, Webb J, Kulkarni M, Dawson D, Sulaibeekh L, Chandrasekaran B, Bucciarelli-Ducci C, Pasquale F, Cowie MR, McKenna WJ, Sheppard MN, Elliott PM, Pennell DJ, Prasad SK (2010) Prognostic significance of myocardial fibrosis in hypertrophic cardiomyopathy. J Am Coll Cardiol 56:867–874

    Article  Google Scholar 

  6. Azevedo CF, Nigri M, Higuchi ML, Pomerantzeff PM, Spina GS, Sampaio RO, Tarasoutchi F, Grinberg M, Rochitte CE (2010) Prognostic significance of myocardial fibrosis quantification by histopathology and magnetic resonance imaging in patients with severe aortic valve disease. J Am Coll Cardiol 56:278–287

    Article  Google Scholar 

  7. Miller AJ (2011) The grossly invisible and generally ignored lymphatics of the mammalian heart. Med Hypotheses 76:604–606

    Article  CAS  Google Scholar 

  8. Cui Y (2010) The role of lymphatic vessels in the heart. Pathophysiology 17:307–314

    Article  Google Scholar 

  9. Ludwig LL, Schertel ER, Pratt JW, McClure DE, Ying AJ, Heck CF, Myerowitz PD (1997) Impairment of left ventricular function by acute cardiac lymphatic obstruction. Cardiovasc Res 33:164–171

    Article  CAS  Google Scholar 

  10. Dashkevich A, Bloch W, Antonyan A, Fries JU, Geissler HJ (2009) Morphological and quantitative changes of the initial myocardial lymphatics in terminal heart failure. Lymphat Res Biol 7:21–27

    Article  CAS  Google Scholar 

  11. Kholova I, Dragneva G, Cermakova P, Laidinen S, Kaskenpaa N, Hazes T, Cermakova E, Steiner I, Yla-Herttuala S (2011) Lymphatic vasculature is increased in heart valves, ischaemic and inflamed hearts and in cholesterol-rich and calcified atherosclerotic lesions. Eur J Clin Invest 41:487–497

    Article  Google Scholar 

  12. Henri O, Pouehe C, Houssari M, Galas L, Nicol L, Edwards-Levy F, Henry JP, Dumesnil A, Boukhalfa I, Banquet S, Schapman D, Thuillez C, Richard V, Mulder P, Brakenhielm E (2016) Selective stimulation of cardiac lymphangiogenesis reduces myocardial edema and fibrosis leading to improved cardiac function following myocardial infarction. Circulation 133(1484–1497):1497

    Google Scholar 

  13. Elliott PM, Anastasakis A, Borger MA, Borggrefe M, Cecchi F, Charron P, Hagege AA, Lafont A, Limongelli G, Mahrholdt H, McKenna WJ, Mogensen J, Nihoyannopoulos P, Nistri S, Pieper PG, Pieske B, Rapezzi C, Rutten FH, Tillmanns C, Watkins H (2014) 2014 ESC Guidelines on diagnosis and management of hypertrophic cardiomyopathy: the task force for the diagnosis and management of hypertrophic cardiomyopathy of the european society of cardiology (ESC). Eur Heart J 35:2733–2779

    Article  Google Scholar 

  14. Nagueh SF, Bierig SM, Budoff MJ, Desai M, Dilsizian V, Eidem B, Goldstein SA, Hung J, Maron MS, Ommen SR, Woo A (2011) American Society of Echocardiography clinical recommendations for multimodality cardiovascular imaging of patients with hypertrophic cardiomyopathy: endorsed by the American Society of Nuclear Cardiology, Society for Cardiovascular Magnetic Resonance, and Society of Cardiovascular Computed Tomography. J Am Soc Echocardiogr 24:473–498

    Article  Google Scholar 

  15. Liu Y, Song Y, Gao G, Ran J, Su W, Li H, Tang Y, Duan F, Sun H (2016) Outcomes of an extended Morrow procedure without a concomitant mitral valve procedure for hypertrophic obstructive cardiomyopathy. Sci Rep 6:29031

    Article  CAS  Google Scholar 

  16. Vuorio T, Tirronen A, Yla-Herttuala S (2017) Cardiac Lymphatics—a new avenue for therapeutics? Trends Endocrinol Metab 28:285–296

    Article  CAS  Google Scholar 

  17. Vieira JM, Norman S, Villa DCC, Cahill TJ, Barnette DN, Gunadasa-Rohling M, Johnson LA, Greaves DR, Carr CA, Jackson DG, Riley PR (2018) The cardiac lymphatic system stimulates resolution of inflammation following myocardial infarction. J Clin Invest 128:3402–3412

    Article  Google Scholar 

  18. Dieterich LC, Seidel CD, Detmar M (2014) Lymphatic vessels: new targets for the treatment of inflammatory diseases. Angiogenesis 17:359–371

    Article  CAS  Google Scholar 

  19. Oliver G (2004) Lymphatic vasculature development. Nat Rev Immunol 4:35–45

    Article  CAS  Google Scholar 

Download references

Funding

This work was supported by National Natural Science Foundation of China (81370327).

Author information

Authors and Affiliations

  1. Cardiology Department, State Key Laboratory of Cardiovascular Disease, National Center for Cardiovascular Diseases, Fuwai Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China

    Xiaowei Jiang, Jingang Cui, Chengzhi Yang, Yunhu Song, Jiansong Yuan, Shengwen Liu, Fenghuan Hu, Weixian Yang & Shubin Qiao

Authors
  1. Xiaowei Jiang
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Jingang Cui
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Chengzhi Yang
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Yunhu Song
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Jiansong Yuan
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Shengwen Liu
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Fenghuan Hu
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Weixian Yang
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Shubin Qiao
    View author publications

    You can also search for this author in PubMed Google Scholar

Contributions

Conception and design: XWJ, SBQ, JGC, YHS, CZY, JSY, SWL; data acquisition: XWJ, SBQ, JGC, YHS, CZY, JSY, SWL, FHH, WXY; data analysis and interpretation: XWJ, JGC, YHS, CZY, FHH, WXY; drafting and finalizing the article: XWJ, SBQ.

Corresponding author

Correspondence to Shubin Qiao.

Ethics declarations

Conflict of interest

We have no conflict of interest to declare.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Jiang, X., Cui, J., Yang, C. et al. Elevated lymphatic vessel density measured by Lyve-1 expression in areas of replacement fibrosis in the ventricular septum of patients with hypertrophic obstructive cardiomyopathy (HOCM). Heart Vessels 35, 78–85 (2020). https://doi.org/10.1007/s00380-019-01463-5

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00380-019-01463-5

Keywords

Search

Navigation